Biomedical Catalyst 2018 Round 2: Late Stage

Key Features

UK SMEs can apply for a share of up to £10 million to work on solving healthcare challenges in a clinical setting or a relevant late stage environment.

Programme:     Innovate UK

Award:     Share of up to £10 million

Opens: 6th Aug 2018

Closes: 3rd Oct 2018

! This scheme is now closed


Biomedical Catalyst supports the development of innovative healthcare products, technologies and processes. These can include:

  • disease prevention and proactive management of health and chronic conditions
  • earlier or better detection and diagnosis of disease, leading to better patient outcomes
  • tailored treatments that either change the underlying disease or offer potential cures


The late stage award supports projects which test a well-developed concept. It should show its effectiveness in an environment that is relevant to the use of the product or process. A late stage project can include:

  • initial human proof-of-concept studies
  • demonstration of clinical utility and effectiveness
  • demonstration of safety and efficacy (including phase I and II clinical trials)
  • developing production mechanisms
  • prototyping
  • market testing
  • intellectual property protection

Innovate UK will support projects from any sector or discipline, including (but not limited to):

  • advanced therapies (cell and gene therapy)
  • precision medicine (both therapy and diagnostic components)
  • diagnostics
  • digital health
  • medical technologies and devices

You should have prior credible research on your proposal, including a demonstration of validation in a relevant model system.


An SME business can:

  • take part in up to 3 applications in this competition round, although you can only be the lead partner in one application in this round
  • lead only one active project in any one Biomedical Catalyst award at any time

You are able to apply for a second project to be funded e.g. you may already hold both an early stage and a late stage award. When the early stage project finishes, you may apply in this round for a late stage award to continue that specific programme of work while still holding your original late stage award.

You will be asked to provide evidence that you have enough resources to run 2 projects at the same time.

If you have research organisations in your consortium, they can share up to 50% of the total eligible project costs.

Large organisations are unable to be partners on any project in this competition.

Funding Costs

Innovate UK expect projects to range in size from £200,000 to £4 million (total project costs).

Projects should last 12 to 36 months and must start before 1 July 2019.


Projects that are too early stage will not be funded.

Projects without sufficient validated prior research will not be funded.

Projects that are too close to market, or already at market will not be funded.

Read Dr Emma Richardson’s blog featuring more information regarding precision medicine and how we could help you with this competition.